Covance Not Cooling...
Health Care: Drugs
Johnson & Johnson (JNJ: NYSE)
$88.09 0.64 | 0.73%
05/17/13 - 04:02 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 14.91B | 24.54B | 19.36B | 15.81B |
| Receivables | 11.31B | 10.58B | 9.77B | 9.65B |
| Inventories | 7.50B | 6.28B | 5.38B | 5.18B |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 46.12B | 54.32B | 47.31B | 39.54B |
| Property, Plant & Equipment, Gross | 34.65B | 31.83B | 30.43B | 29.25B |
| Accumulated Depreciation & Depletion | 18.56B | 17.09B | 15.87B | 14.49B |
| Property, Plant & Equipment, Net | 16.10B | 14.74B | 14.55B | 14.76B |
| Intangibles | 28.75B | 18.14B | 16.72B | 16.32B |
| Other Non-Current Assets | 3.42B | 3.77B | 3.94B | 3.69B |
| Total Non-Current Assets | 75.23B | 59.33B | 55.60B | 55.14B |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 121.35B | 113.64B | 102.91B | 94.68B |
| Accounts Payable | 5.83B | 5.72B | 5.62B | 5.54B |
| Short Term Debt | 0.00 | 6.66B | 7.62B | 0.00 |
| Other Current Liabilities | 1.06B | 854.00M | 578.00M | 442.00M |
| Total Current Liabilities | 24.26B | 22.81B | 23.07B | 21.73B |
| Long Term Debt | 11.49B | 12.97B | 9.16B | 8.22B |
| Deferred Income Taxes | 3.14B | 1.80B | 1.45B | 1.42B |
| Other Non-Current Liabilities | 17.63B | 18.98B | 12.65B | 12.72B |
| Minority Interest | -339.00M | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 32.26B | 33.75B | 23.26B | 22.36B |
| Total Liabilities | 56.52B | 56.56B | 46.33B | 44.09B |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 64.83B | 57.08B | 56.58B | 50.59B |
| Common Par | 3.12B | 3.12B | 3.12B | 3.12B |
| Additional Paid In Capital | 0.00 | 0.00 | 0.00 | 0.00 |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | 85.99B | 81.25B | 77.77B | 70.31B |
| Treasury Stock | -18.48B | -21.66B | -20.78B | -19.78B |
| Other Equity Adjustments | -5.81B | -5.63B | -3.53B | -3.06B |
| Total Capitalization | 76.32B | 70.05B | 65.74B | 58.81B |
| Total Equity | 64.83B | 57.08B | 56.58B | 50.59B |
| Total Liabilities & Stock Equity | 121.35B | 113.64B | 102.91B | 94.68B |
| Total Common Shares Outstanding | 2.80B | 2.72B | 2.74B | 2.75B |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 682.71M | 395.48M | 381.75M | 365.52M |
| Basic Weighted Shares Outstanding | 2.75B | 2.74B | 2.75B | 2.76B |
| Diluted Weighted Shares Outstanding | 2.81B | 2.78B | 2.79B | 2.79B |
| Number of Employees | 127600 | 117900 | 114000 | 115500 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with JNJ
- Portfolio NameUser Type
- UserSlip's Portfolio
- Userralphd5-12
- ContributorStocks Fund Managers Love Q...
- ProGeorge Soros
- ContributorGame of Thrones Portfolio
- UserCapt Jer
- ContributorRocket Stocks for the Week ...
- ContributorShort Squeezes for the Week...
- UserQuicksilver55
- Userlennyvb Portfolio 1
Latest JNJ Headlines from TheStreet
- An Investor's Choice: J&J or Baxter International? 04.19.13 | 06:04 am
- Cramer's 'Mad Money' Recap: Haves and Have-Nots 04.17.13 | 08:04 pm
- 3 Stocks Advancing The Health Care Sector 04.17.13 | 01:04 pm
- Cramer's 6 Stocks in 60 Seconds: ESRX URI BBBY JNJ WDAY TGT 04.17.13 | 12:04 pm
- 5 Stocks Fund Managers Love for 2013 04.17.13 | 11:04 am
- Dow Today: Johnson & Johnson (JNJ) Leads The Day Higher, Bank Of America Corporation (BAC) Lags 04.17.13 | 10:04 am
- Google Offers Next Key Earnings Report 04.17.13 | 08:04 am
- Cramer's Top Stock Picks: KO JNJ GLD HK 04.17.13 | 06:04 am
- Dow Today: Johnson & Johnson (JNJ) Higher 04.16.13 | 11:04 am
- Morning Briefing: 10 Things You Should Know 04.16.13 | 08:04 am
Press Releases for JNJ
- Johnson & Johnson Announces Sale Of Elan American Depositary Shares To Elan - PR Newswire 04.18.13 | 09:04 am
- Johnson & Johnson To Webcast Annual Meeting Of Shareholders - PR Newswire 04.11.13 | 07:04 am
- Look And Feel Great This Spring, Despite Allergy Symptoms - PR Newswire 04.09.13 | 07:04 am
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Johnson & Johnson To Host Analyst Conference Call On First-Quarter Results - PR Newswire 03.19.13 | 10:03 am
- Cordis Acquires Flexible Stenting Solutions, Inc. - Business Wire 03.12.13 | 09:03 am
- Johnson & Johnson Comments On Venezuelan Currency Devaluation - PR Newswire 02.25.13 | 07:02 am
- Johnson & Johnson To Participate In 2013 Citi Global Health Care Conference - PR Newswire 02.20.13 | 09:02 am
- Johnson & Johnson To Participate In 2013 Leerink Swann Global Health Care Conference - PR Newswire 02.06.13 | 10:02 am
- Johnson & Johnson Presents Growth Strategies For Medical Devices & Diagnostics Segment - PR Newswire 01.22.13 | 09:01 am
Partner Headlines for JNJ
- Some Dividend ETFs Outperforming The S&P 500 - Investor's Business Daily 05.16.13 | 05:05 pm
- Nature's Sunshine Products, Inc. (NATR) Ex-Dividend Date Scheduled for May 16, 2013 - NASDAQ 05.15.13 | 01:05 pm
- Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for May 16, 2013 - NASDAQ 05.15.13 | 01:05 pm
- Dr. Marc Faber's Gloomy Market Outlook - Seeking Alpha 05.14.13 | 09:05 am
- Theravance, Glaxo, Elan Star In Biotech Soap Opera - Investor's Business Daily 05.13.13 | 05:05 pm
- Should the market's new highs scare you? - MSN Money 05.13.13 | 12:05 pm
- Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for May 14, 2013 - NASDAQ 05.13.13 | 11:05 am
- Alzheimer's keeps frustrating big pharma - MSN Money 05.13.13 | 10:05 am
- Buffett Style Valuation Of Johnson & Johnson - Seeking Alpha 05.13.13 | 09:05 am
- Johnson & Johnson: An Investment In A Healthcare Conglomerate That Cannot Go Wrong - Seeking Alpha 05.13.13 | 09:05 am
